Page last updated: 2024-08-24

aptiganel and Stroke

aptiganel has been researched along with Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barber, PA; Buchan, AM; Hill, MD; Hoyte, L1
Albers, GW; Goldstein, LB; Hall, D; Lesko, LM1
Becker, KJ; Tirschwell, DL1
Birmingham, K1
Albers, GW; Goldstein, LB1
Sareen, D1

Reviews

2 review(s) available for aptiganel and Stroke

ArticleYear
The rise and fall of NMDA antagonists for ischemic stroke.
    Current molecular medicine, 2004, Volume: 4, Issue:2

    Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanidines; Humans; Indoles; Ischemia; N-Methylaspartate; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Stroke

2004
Neuroprotective agents in acute ischemic stroke.
    The Journal of the Association of Physicians of India, 2002, Volume: 50

    Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles

2002

Trials

1 trial(s) available for aptiganel and Stroke

ArticleYear
Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
    JAMA, 2001, Dec-05, Volume: 286, Issue:21

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Guanidines; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Survival Analysis; Time Factors

2001

Other Studies

3 other study(ies) available for aptiganel and Stroke

ArticleYear
Ensuring patient safety in clinical trials for treatment of acute stroke.
    JAMA, 2001, Dec-05, Volume: 286, Issue:21

    Topics: Clinical Trials as Topic; Fibrinolytic Agents; Guanidines; Humans; Neuroprotective Agents; Risk; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator

2001
Future of neuroprotective drugs in doubt.
    Nature medicine, 2002, Volume: 8, Issue:1

    Topics: Clinical Trials as Topic; Excitatory Amino Acid Antagonists; Guanidines; Humans; Multicenter Studies as Topic; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Stroke; Tissue Plasminogen Activator

2002
Patient safety in trials of therapy for acute ischemic stroke.
    JAMA, 2002, Feb-27, Volume: 287, Issue:8

    Topics: Brain Ischemia; Clinical Trials as Topic; Guanidines; Humans; Neuroprotective Agents; Safety; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator

2002